Publications by authors named "Roger A Barker"

Claim this Profile
C
Cell transplantation therapies in Huntington's disease - Current status and future directions.
Angelica E Guiloff, Roger A Barker

Pharmacol Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell transcriptomics identifies chondrocyte differentiation dynamics in vivo and in vitro.
John E G Lawrence, Steven Woods, Kenny Roberts, Dinithi Sumanaweera, Petra Balogh, Roger A Barker

Dev Cell· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addendum to Dopamine Cell-Based Replacement Therapies.
Saeed Kayhanian, Roger A Barker

Cold Spring Harb Perspect Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rs6971 TSPO Polymorphism Does Not Influence Disease Presentation or Progression in Parkinson's Disease rs6971 TSPO Polymorphism in PD.
Bina Patel, Marta Camacho, Jonathan R Evans, David P Breen, Thomas Foltynie, Roger A Barker

Mov Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial highlights: Dopamine cell-replacement therapies.
Saeed Kayhanian, Roger A Barker

J Parkinsons Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LINE-1 retrotransposons mediate cis-acting transcriptional control in human pluripotent stem cells and regulate early brain development.
Anita Adami, Raquel Garza, Patricia Gerdes, Pia A Johansson, Fereshteh Dorazehi, Roger A Barker

Cell Genom· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem cell-derived dopamine cell therapies for Parkinson's disease: what have the first trials shown?
Roger A Barker, Malin Parmar

Brain· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Analysis of the X Chromosome Associates Loci with Progression of Parkinson's Disease.
Yu Liao, Hao Wu, Junhao Wang, Jean-Christophe Corvol, Jodi Maple-Grødem, Roger A Barker

Mov Disord· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the distribution of neurotransmitters to resting-state functional connectivity in Parkinson's disease.
Weihua Li, Nicholas P Lao-Kaim, Runtian Li, Antonio Martín-Bastida, Andreas-Antonios Roussakis, Roger A Barker

Brain Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological and pupillary evidence for the noradrenergic contribution to reinforcement learning in Parkinson's disease.
Claire O'Callaghan, Frank H Hezemans, Naresh Subramaniam, Rong Ye, Kamen A Tsvetanov, Roger A Barker

Commun Biol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.
Cristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber, Roger A Barker, David T Dexter

Mov Disord· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Y chromosome loss on the risk of Parkinson's disease and progression.
Junhao Wang, Xinyi Chen, Wenxuan Du, Cha Lin, Yu Liao, Roger A Barker

EBioMedicine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-adrenoceptor drugs and progression to Parkinson's disease milestones in a large pooled incident cohort.
Ruwani S Wijeyekoon, Marta Camacho, David Bäckström, Lars Forsgren, Rachael A Lawson, Roger A Barker

NPJ Parkinsons Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 14-Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's.
Natalia E Owen, Zanna J Voysey, Jonathan A Holbrook, Maura Malpetti, Clara Le Draoulec, Roger A Barker

Ann Clin Transl Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of gene therapy for Parkinson's disease.
Roger A Barker, Philip C Buttery

Lancet Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional cell-cell interactions promote direct reprogramming of patient fibroblasts into functional and transplantable neurons.
Janko Kajtez, Kerstin Laurin, Fredrik Nilsson, Andreas Bruzelius, Efrain Cepeda-Prado, Roger A Barker

Sci Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease.
Roger A Barker, Nicholas P Lao-Kaim, Natalie Valle Guzman, Dilan Athauda, Hjalmar Bjartmarz

Nat Biotechnol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep abnormalities are associated with greater cognitive deficits and disease activity in Huntington's disease: a 12-year polysomnographic study.
Zanna J Voysey, Anna O G Goodman, Lorraine Rogers, Jonathan A Holbrook, Alpar S Lazar, Roger A Barker

Brain Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson's disease-like neurodegeneration.
Hélèna L Denis, Aurélie de Rus Jacquet, Melanie Alpaugh, Michel Panisset, Roger A Barker

Fluids Barriers CNS· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity.
Melanie Alpaugh, Juan Lantero-Rodriguez, Andrea L Benedet, Uriel Manseau, Martine Boutin, Roger A Barker

J Neurol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on immune-based alpha-synuclein trials in Parkinson's disease.
Maha Alfaidi, Roger A Barker, Wei-Li Kuan

J Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HOX gene expression in the developing human spine.
John E G Lawrence, Kenny Roberts, Elizabeth Tuck, Tong Li, Lira Mamanova, Roger A Barker

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A spatial human thymus cell atlas mapped to a continuous tissue axis.
Nadav Yayon, Veronika R Kedlian, Lena Boehme, Chenqu Suo, Brianna T Wachter, Roger A Barker

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-omic atlas of human embryonic skeletal development.
Ken To, Lijiang Fei, J Patrick Pett, Kenny Roberts, Raphael Blain, Roger A Barker

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop.
Roger A Barker, Mart Saarma, Clive N Svendsen, Catherine Morgan, Alan Whone

J Parkinsons Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis